Aviance Capital Partners’s Myriad Genetics MYGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-15,035	Closed	-$514K	–	228
2014 Q1	$514K	Buy	+15,035	New	+$514K	0.22%	130